Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Workgroup report: Implementing a national occupational reproductive research agenda--decade one and beyond.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: National Institute of Environmental Health Sciences Country of Publication: United States NLM ID: 0330411 Publication Model: Print Cited Medium: Print ISSN: 0091-6765 (Print) Linking ISSN: 00916765 NLM ISO Abbreviation: Environ Health Perspect Subsets: MEDLINE
- Publication Information:
Original Publication: Research Triangle Park, N. C. National Institute of Environmental Health Sciences.
- Subject Terms:
- Abstract:
The initial goal of occupational reproductive health research is to effectively study the many toxicants, physical agents, and biomechanical and psychosocial stressors that may constitute reproductive hazards in the workplace. Although the main objective of occupational reproductive researchers and clinicians is to prevent recognized adverse reproductive outcomes, research has expanded to include a broader spectrum of chronic health outcomes potentially affected by reproductive toxicants. To aid in achieving these goals, the National Institute for Occupational Safety and Health, along with its university, federal, industry, and labor colleagues, formed the National Occupational Research Agenda (NORA) in 1996. NORA resulted in 21 research teams, including the Reproductive Health Research Team (RHRT). In this report, we describe progress made in the last decade by the RHRT and by others in this field, including prioritizing reproductive toxicants for further study; facilitating collaboration among epidemiologists, biologists, and toxicologists; promoting quality exposure assessment in field studies and surveillance; and encouraging the design and conduct of priority occupational reproductive studies. We also describe new tools for screening reproductive toxicants and for analyzing mode of action. We recommend considering outcomes such as menopause and latent adverse effects for further study, as well as including exposures such as shift work and nanomaterials. We describe a broad domain of scholarship activities where a cohesive system of organized and aligned work activities integrates 10 years of team efforts and provides guidance for future research.
- References:
Toxicol Sci. 2002 Jul;68(1):184-99. (PMID: 12075121)
Epidemiology. 2004 Jul;15(4):466-70. (PMID: 15232408)
Curr Opin Drug Discov Devel. 2002 Jan;5(1):72-8. (PMID: 11865675)
Nature. 2001 Feb 15;409(6822):860-921. (PMID: 11237011)
Teratology. 2002 Mar;65(3):131-44. (PMID: 11877777)
Toxicol Sci. 2004 Feb;77(2):315-24. (PMID: 14600290)
Nat Rev Genet. 2002 May;3(5):391-7. (PMID: 11988764)
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11. (PMID: 14578152)
Ann Intern Med. 1978 Aug;89(2):157-61. (PMID: 677576)
Toxicol Sci. 2000 Dec;58(2):270-81. (PMID: 11099639)
Environ Health Perspect. 2004 Aug;112(11):1137-42. (PMID: 15289156)
Toxicol Sci. 2000 Dec;58(2):253-69. (PMID: 11099638)
Maturitas. 1979 Feb;1(3):175-81. (PMID: 502875)
Nat Biotechnol. 2003 Oct;21(10):1166-70. (PMID: 14520401)
Reprod Toxicol. 1994 Mar-Apr;8(2):121-35. (PMID: 8032123)
Environ Health Perspect. 2004 Mar;112(4):495-505. (PMID: 15033600)
Nat Genet. 2001 Nov;29(3):306-9. (PMID: 11600885)
Toxicol Sci. 2000 Mar;54(1):138-53. (PMID: 10746941)
Int J Hyg Environ Health. 2003 Aug;206(4-5):447-52. (PMID: 12971700)
Curr Opin Genet Dev. 2004 Jun;14(3):233-40. (PMID: 15172664)
J Matern Fetal Neonatal Med. 2003 May;13(5):292-9. (PMID: 12916677)
Toxicol Sci. 2004 Jan;77(1):3-5. (PMID: 14756123)
Annu Rev Pharmacol Toxicol. 2000;40:335-52. (PMID: 10836140)
Reprod Toxicol. 1997 Jan-Feb;11(1):123-60. (PMID: 9138630)
Birth Defects Res C Embryo Today. 2004 Dec;72(4):300-12. (PMID: 15662709)
JAMA. 1999 Feb 10;281(6):552-7. (PMID: 10022112)
Nat Rev Genet. 2005 Apr;6(4):287-98. (PMID: 15803198)
Reprod Toxicol. 2000 Jul-Aug;14(4):293-301. (PMID: 10908832)
Nature. 2001 Feb 15;409(6822):928-33. (PMID: 11237013)
Am J Ind Med. 1993 Jan;23(1):135-41. (PMID: 8422043)
Am J Epidemiol. 2002 Aug 15;156(4):311-8. (PMID: 12181100)
Reprod Toxicol. 2003 Sep-Oct;17(5):519-25. (PMID: 14555189)
Environ Health Perspect. 2003 Apr;111(4):584-92. (PMID: 12676620)
Environ Health Perspect. 2004 Mar;112(3):331-8. (PMID: 14998749)
Nat Genet. 1999 Jul;22(3):231-8. (PMID: 10391209)
Physiol Genomics. 2003 Oct 17;15(2):127-41. (PMID: 12915738)
Acta Physiol Hung. 2003;90(3):195-206. (PMID: 14594190)
Chem Res Toxicol. 2003 Oct;16(10):1338-58. (PMID: 14565775)
J Natl Cancer Inst. 1972 Mar;48(3):605-13. (PMID: 5058966)
N Engl J Med. 2003 Apr 17;348(16):1527-36. (PMID: 12700372)
Birth Defects Res B Dev Reprod Toxicol. 2005 Apr;74(2):157-63. (PMID: 15834899)
J Clin Epidemiol. 2004 May;57(5):484-96. (PMID: 15196619)
Nat Rev Genet. 2005 Feb;6(2):95-108. (PMID: 15716906)
Gene. 1999 Jul 8;234(2):177-86. (PMID: 10395891)
Reprod Toxicol. 2004 Mar-Apr;18(2):157-87. (PMID: 15019718)
Environ Health Perspect. 2004 Nov;112(15):1519-26. (PMID: 15531437)
Science. 2001 Feb 16;291(5507):1304-51. (PMID: 11181995)
Am J Health Syst Pharm. 1996 Jul 15;53(14):1669-85. (PMID: 8827233)
Toxicol Sci. 2004 Sep;81(1):78-89. (PMID: 15187238)
Toxicol Sci. 2003 Apr;72(2):314-30. (PMID: 12655037)
MMWR Morb Mortal Wkly Rep. 1995 Sep 22;44(37):694-9. (PMID: 7666849)
Reprod Toxicol. 2005 Jan-Feb;19(3):353-66. (PMID: 15686870)
Scand J Work Environ Health. 1990;16 Suppl 1:67-73. (PMID: 2189223)
Toxicol Sci. 2003 Feb;71(2):251-62. (PMID: 12563111)
Reprod Toxicol. 1997 Mar-Jun;11(2-3):267-9. (PMID: 9100300)
Am J Health Syst Pharm. 1999 Jul 15;56(14):1427-32. (PMID: 10428450)
Genet Epidemiol. 2005 May;28(4):368-75. (PMID: 15712341)
Environ Health Perspect. 2002 Dec;110 Suppl 6:1013-24. (PMID: 12634133)
J Fam Pract. 1998 Feb;46(2):168-76. (PMID: 9487325)
Curr Med Chem. 2000 Feb;7(2):211-47. (PMID: 10637363)
Am J Epidemiol. 2004 Sep 1;160(5):484-91. (PMID: 15321846)
Scand J Work Environ Health. 2003 Oct;29(5):337-46. (PMID: 14584514)
- Accession Number:
0 (Hazardous Substances)
- Publication Date:
Date Created: 20060302 Date Completed: 20060721 Latest Revision: 20231105
- Publication Date:
20231105
- Accession Number:
PMC1392239
- Accession Number:
10.1289/ehp.8458
- Accession Number:
16507468
No Comments.